Comparative efficacy of BAC-derived recombinant SB-1 vaccine and the parent wild type strain in preventing replication, shedding and disease induced by virulent Marek's disease virus

Research in Veterinary Science

Volumn 89, Issue 1, 2010, Pages 140-145

  Singh, S M ^a   Baigent, S J ^a   Petherbridge, L J ^a   Smith, L P ^a   Nair, V K ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Bacterial artificial chromosome; Chicken; Marek's disease; Real time PCR; Vaccination

Indexed keywords

MAREK DISEASE VACCINE; PSB 1 VACCINE; RECOMBINANT VACCINE; SB VACC; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHICKEN; CLONING VECTOR; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; FEMALE; INFECTION PREVENTION; MARDIVIRUS; MAREK DISEASE; NONHUMAN; STRAIN DIFFERENCE; TREATMENT RESPONSE; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; CHICKENS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, MOLECULAR; DNA, RECOMBINANT; DNA, VIRAL; HERPESVIRUS 2, GALLID; MAREK DISEASE; MAREK DISEASE VACCINES; VACCINES, DNA; VIRULENCE; VIRUS REPLICATION; VIRUS SHEDDING;

BACTERIA (MICROORGANISMS); GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE;

EID: 77952889061     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2010.01.010     Document Type: Article

References (47)

1. Altman D.G. Practical Statistics for Medical Research 1991, Chapman and Hall, London, pp. 365-395.
2. Baigent S., Davison F. Marek's disease virus: biology and life cycle. Marek's Disease, An Evolving Problem 2004, 62-77. Elsevier Academic Press, Oxford. first ed. F. Davison, V. Nair (Eds.).
3. Baigent S.J., Petherbridge L.J., Howes K., Smith L.P., Currie R.J., Nair V.K. Absolute quantitation of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. Journal of Virological Methods 2005, 123:53-64.
4. Baigent S.J., Smith L.P., Currie R.J., Nair V.K. Replication kinetics of Marek's disease vaccine virus in feathers and lymphoid tissues using PCR and virus isolation. Journal of General Virology 2005, 86:2989-2998.
5. Baigent S.J., Petherbridge L.J., Smith L.P., Zhao Y., Chesters P.M., Nair V.K. Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease. Journal of General Virology 2006, 87:769-776.
6. Baigent S.J., Smith L.P., Currie R.J., Nair V.K. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model. Avian Pathology 2007, 36:467-474.
7. Blondeau C., Chbab N., Beaumont C., Courvoisier K., Osterrieder N., Vautherot J.F., Denesvre C. A full UL13 open reading frame in Marek's disease virus (MDV) is dispensable for tumor formation and feather follicle tropism and cannot restore horizontal virus transmission of rRB-1B in vivo. Veterinary Research 2007, 38:419-433.
8. Bublot M., Sharma J. Vaccination against Marek's disease. Marek's Disease, An Evolving Problem 2004, 168-185. Elsevier Academic Press, Oxford. first ed. F. Davison, V. Nair (Eds.).
9. Bumstead N., Sillibourne J., Rennie M., Ross N., Davison F. Quantification of Marek's disease virus in chicken lymphocytes using the polymerase chain reaction with fluorescence detection. Journal of Virological Methods 1997, 65:75-81.
10. Buscaglia C., Nervi P., Risso M. Characterization of four very virulent Argentinean strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses. Avian Pathology 2004, 33:190-195.
11. Calnek B.W. Pathogenesis of Marek's disease virus infection. Current Topics in Microbiology and Immunology 2001, 255:25-55.
12. Calnek B.W., Adldinger H.K., Kahn D.E. Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Diseases 1970, 14:219-233.
13. Calnek B.W., Carlisle J.C., Fabricant J., Murthy K.K., Schat K.A. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus. American Journal of Veterinary Research 1979, 40:541-548.
14. Calnek B.W., Schat K.A., Peckham M.C., Fabricant J. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease. Avian Diseases 1983, 27:844-849.
15. Davison F., Nair V. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?. Expert Review of Vaccines 2005, 4:77-88.
16. Gimeno I.M. Marek's disease vaccines: a solution for today but a worry for tomorrow?. Vaccine 2008, 26(Suppl. 3):C31-41.
17. Gimeno I.M., Cortes A.L., Silva R.F. Load of challenge Marek's disease virus DNA in blood as a criterion for early diagnosis of Marek's disease tumours. Avian Diseases 2008, 52:203-208.
18. Islam A., Walkden-Brown S.W. Quantitative profiling of the shedding rate of the three Marek's disease virus (MDV) serotypes reveals that challenge with virulent MDV markedly increases shedding of vaccinal viruses. Journal of General Virology 2007, 88:2121-2128.
19. Islam A., Harrison B., Cheetham B.F., Mahony T.J., Young P.L., Walkden-Brown S.W. Differential amplification and quantitation of Marek's disease viruses using real-time polymerase chain reaction. Journal of Virological Methods 2004, 119:103-113.
20. Islam A.F., Walkden-Brown S.W., Islam A., Underwood G.J., Groves P.J. Relationship between Marek's disease virus load in peripheral blood lymphocytes at various stages of infection and clinical Marek's disease in broiler chickens. Avian Pathology 2006, 35:42-48.
21. Islam A., Cheetham B.F., Mahony T.J., Young P.L., Walkden-Brown S.W. Absolute quantitation of Marek's disease virus and herpesvirus of turkeys in chicken lymphocyte, feather tip and dust samples using real-time PCR. Journal of Virological Methods 2006, 132:127-134.
22. Islam A.F., Walkden-Brown S.W., Groves P.J., Underwood G.J. Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge. Australian Veterinary Journal 2007, 85:348-355.
23. Izumiya Y., Jang H.K., Ono M., Mikami T. A complete genomic DNA sequence of Marek's disease virus type 2, strain HPRS24. Current Topics in Microbiology and Immunology 2001, 255:191-221.
24. Jarosinski K.W., Margulis N.G., Kamil J.P., Spatz S.J., Nair V.K., Osterrieder N. Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. Journal of Virology 2007, 81:10575-10587.
25. King D., Page D., Schat K.A., Calnek B.W. Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines. Avian Diseases 1981, 25:74-81.
26. Lee L.F., Liu X., Witter R.L. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. Journal of Immunology 1983, 130:1003-1006.
27. Nair V. Evolution of Marek's disease - a paradigm for incessant race between the pathogen and the host. The Veterinary Journal 2005, 170:175-183.
28. Petherbridge L., Howes K., Baigent S.J., Sacco M.A., Evans S., Osterrieder N., Nair V.K. Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. Journal of Virology 2003, 77:8712-8718.
29. Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., Nair V.K. Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. Journal of Virology 2004, 78:13376-13380.
30. Petherbridge L., Xu H., Zhao Y., Smith L.P., Simpson J., Baigent S., Nair V.K. Cloning of Gallid herpesvirus 3 (Marek's disease virus serotype-2) genome as infectious bacterial artificial chromosomes for analysis of viral gene functions. Journal of Virological Methods 2009, 158:11-17.
31. Renz K.G., Islam A., Cheetham B.F., Walkden-Brown S.W. Absolute quantification using real-time polymerase chain reaction of Marek's disease virus serotype 2 in field dust samples, feather tips and spleens. Journal of Virological Methods 2006, 135:186-191.
32. Schat K.A., Calnek B.W. Characterization of an apparently nononcogenic Marek's disease virus. Journal of the National Cancer Institute 1978, 60:1075-1082.
33. Schat K.A., Nair V. Marek's disease. Diseases of Poultry 2008, 452-514. Blackwell Publishing, Ames. 12th ed. Y.M. Saif (Ed.).
34. Schat K.A., Calnek B.W., Fabricant J. Characterisation of two highly oncogenic strains of Marek's disease virus. Avian Pathology 1982, 11:593-605.
35. Sharma J.M., Graham C.K. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free MD vaccine. Avian Diseases 1982, 26:860-870.
36. Spatz S.J., Zhao Y., Petherbridge L., Smith L.P., Baigent S.J., Nair V. Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus. Virus Genes 2007, 35:753-766.
37. Witter R.L. Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus. Avian Pathology 1982, 11:49-62.
38. Witter R.L. New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: comparative efficacy. Avian Diseases 1987, 31:752-765.
39. Witter R.L. Increased virulence of Marek's disease virus field isolates. Avian Diseases 1997, 41:149-163.
40. Witter R.L. Marek's disease vaccines - past, present and future (chicken vs. virus - a battle of the centuries). Current Progress on Marek's Disease Research - Proceedings of the Sixth International Symposium on Marek's Disease 2001, 1-9. American Association of Avian Pathologists, Pennsylvania. K.A. Schat, R.W. Morgan, M.S. Parcells, J.L. Spencer (Eds.).
41. Witter R.L. Marek's disease: the continuing struggle between pathogen and host. The Veterinary Journal 2005, 170:149-150.
42. Witter R.L., Lee L.F. Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies. Avian Pathology 1984, 13:75-92.
43. Witter R.L., Sharma J.M., Lee L.F., Opitz H.M., Henry C.W. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers. Avian Diseases 1984, 28:44-60.
44. Witter R.L., Sharma J.M., Chase W.B., Halvorson D.A., Sivanandan V. Field trials to test the efficacy of polyvalent Marek's disease vaccines in layer and broiler breeder chickens. Poultry Science 1985, 64:2280-2286.
45. Witter R.L., Lee L.F., Sharma J.M. Biological diversity among serotype 2 Marek's disease viruses. Avian Diseases 1990, 34:944-957.
46. Witter R.L., Gimeno I.M., Reed W.M., Bacon L.D. An acute form of transient paralysis induced by highly virulent strains of Marek's disease virus. Avian Diseases 1999, 43:704-720.
47. Witter R.L., Calnek B.W., Buscaglia C., Gimeno I.M., Schat K.A. Classification of Marek's disease viruses according to pathotype - philosophy and methodology. Avian Pathology 2005, 34:75-90.